Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas

Csaba Lódi, Erzsébet Szabó, Agnes Holczbauer, Enkhjargal Batmunkh, Attila Szíjártó, P. Kupcsulik, I. Kovalszky, S. Paku, G. Illyés, András Kiss, Z. Schaff

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The recently identified claudins are dominant components of tight junctions, responsible for cell adhesion, polarity and paracellular permeability. Certain claudins have been shown to have relevance in tumor development, with some of them, especially claudin-4, even suggested as future therapeutic target. The aim of the present study was to analyze the expression of claudin-4 in the biliary tree, biliary tract cancers and hepatocellular carcinomas. A total of 107 cases were studied: 53 biliary tract cancers, 50 hepatocellular carcinomas, 10 normal liver and 10 normal extrahepatic biliary duct samples, Immunohistochemical analysis was performed on conventional specimens and on tissue microarrays as well. Claudin-4 was further investigated by Western blot analysis and real-time RT-PCR. Intense membranous immunolabeling was found for claudin-4 in all biliary tract cancers unrelated to the primary site of origin, namely intrahepatic, extrahepatic or gallbladder cancers. Normal biliary epithelium showed weak positivity for claudin-4. In contrast, normal hepatocytes and tumor cells of hepatocellular carcinomas did not express claudin-4. The results of Western immunoblot analysis and real-time RT-PCR were in correlation with the immunohistochemical findings. Cytokeratins, as CK7 (92%) and CK19 (83%) were mostly positive in biliary tract cancers, however, one-third of hepatocellular carcinomas also expressed CK7 (34%). HSA antibody (HepPar1) reacted with the majority of hepatocellular carcinomas (86%), while being positive in a low percentage of the biliary tract cancers (8%). In conclusion, this is the first report of a significantly increased claudin-4 expression in biliary tract cancers, which represents a novel feature of tumors of biliary tract origin. Claudin-4 expression seems to be a useful marker in differentiating biliary tract cancers from hepatocellular carcinomas and could well become a potential diagnostic tool.

Original languageEnglish
Pages (from-to)460-469
Number of pages10
JournalModern Pathology
Volume19
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Claudin-4
Biliary Tract Neoplasms
Hepatocellular Carcinoma
Claudins
Biliary Tract
Real-Time Polymerase Chain Reaction
Far-Western Blotting
Gallbladder Neoplasms
Neoplasms
Cell Polarity
Tight Junctions
Keratins
Cell Adhesion
Hepatocytes
Permeability
Epithelium
Western Blotting

Keywords

  • Biliary tract cancer
  • Claudin-4
  • Hepatocellular carcinoma
  • Liver
  • Tight junction

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. / Lódi, Csaba; Szabó, Erzsébet; Holczbauer, Agnes; Batmunkh, Enkhjargal; Szíjártó, Attila; Kupcsulik, P.; Kovalszky, I.; Paku, S.; Illyés, G.; Kiss, András; Schaff, Z.

In: Modern Pathology, Vol. 19, No. 3, 03.2006, p. 460-469.

Research output: Contribution to journalArticle

Lódi, Csaba ; Szabó, Erzsébet ; Holczbauer, Agnes ; Batmunkh, Enkhjargal ; Szíjártó, Attila ; Kupcsulik, P. ; Kovalszky, I. ; Paku, S. ; Illyés, G. ; Kiss, András ; Schaff, Z. / Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. In: Modern Pathology. 2006 ; Vol. 19, No. 3. pp. 460-469.
@article{c63f0bb6d65148c3b4641be9274a326e,
title = "Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas",
abstract = "The recently identified claudins are dominant components of tight junctions, responsible for cell adhesion, polarity and paracellular permeability. Certain claudins have been shown to have relevance in tumor development, with some of them, especially claudin-4, even suggested as future therapeutic target. The aim of the present study was to analyze the expression of claudin-4 in the biliary tree, biliary tract cancers and hepatocellular carcinomas. A total of 107 cases were studied: 53 biliary tract cancers, 50 hepatocellular carcinomas, 10 normal liver and 10 normal extrahepatic biliary duct samples, Immunohistochemical analysis was performed on conventional specimens and on tissue microarrays as well. Claudin-4 was further investigated by Western blot analysis and real-time RT-PCR. Intense membranous immunolabeling was found for claudin-4 in all biliary tract cancers unrelated to the primary site of origin, namely intrahepatic, extrahepatic or gallbladder cancers. Normal biliary epithelium showed weak positivity for claudin-4. In contrast, normal hepatocytes and tumor cells of hepatocellular carcinomas did not express claudin-4. The results of Western immunoblot analysis and real-time RT-PCR were in correlation with the immunohistochemical findings. Cytokeratins, as CK7 (92{\%}) and CK19 (83{\%}) were mostly positive in biliary tract cancers, however, one-third of hepatocellular carcinomas also expressed CK7 (34{\%}). HSA antibody (HepPar1) reacted with the majority of hepatocellular carcinomas (86{\%}), while being positive in a low percentage of the biliary tract cancers (8{\%}). In conclusion, this is the first report of a significantly increased claudin-4 expression in biliary tract cancers, which represents a novel feature of tumors of biliary tract origin. Claudin-4 expression seems to be a useful marker in differentiating biliary tract cancers from hepatocellular carcinomas and could well become a potential diagnostic tool.",
keywords = "Biliary tract cancer, Claudin-4, Hepatocellular carcinoma, Liver, Tight junction",
author = "Csaba L{\'o}di and Erzs{\'e}bet Szab{\'o} and Agnes Holczbauer and Enkhjargal Batmunkh and Attila Sz{\'i}j{\'a}rt{\'o} and P. Kupcsulik and I. Kovalszky and S. Paku and G. Illy{\'e}s and Andr{\'a}s Kiss and Z. Schaff",
year = "2006",
month = "3",
doi = "10.1038/modpathol.3800549",
language = "English",
volume = "19",
pages = "460--469",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas

AU - Lódi, Csaba

AU - Szabó, Erzsébet

AU - Holczbauer, Agnes

AU - Batmunkh, Enkhjargal

AU - Szíjártó, Attila

AU - Kupcsulik, P.

AU - Kovalszky, I.

AU - Paku, S.

AU - Illyés, G.

AU - Kiss, András

AU - Schaff, Z.

PY - 2006/3

Y1 - 2006/3

N2 - The recently identified claudins are dominant components of tight junctions, responsible for cell adhesion, polarity and paracellular permeability. Certain claudins have been shown to have relevance in tumor development, with some of them, especially claudin-4, even suggested as future therapeutic target. The aim of the present study was to analyze the expression of claudin-4 in the biliary tree, biliary tract cancers and hepatocellular carcinomas. A total of 107 cases were studied: 53 biliary tract cancers, 50 hepatocellular carcinomas, 10 normal liver and 10 normal extrahepatic biliary duct samples, Immunohistochemical analysis was performed on conventional specimens and on tissue microarrays as well. Claudin-4 was further investigated by Western blot analysis and real-time RT-PCR. Intense membranous immunolabeling was found for claudin-4 in all biliary tract cancers unrelated to the primary site of origin, namely intrahepatic, extrahepatic or gallbladder cancers. Normal biliary epithelium showed weak positivity for claudin-4. In contrast, normal hepatocytes and tumor cells of hepatocellular carcinomas did not express claudin-4. The results of Western immunoblot analysis and real-time RT-PCR were in correlation with the immunohistochemical findings. Cytokeratins, as CK7 (92%) and CK19 (83%) were mostly positive in biliary tract cancers, however, one-third of hepatocellular carcinomas also expressed CK7 (34%). HSA antibody (HepPar1) reacted with the majority of hepatocellular carcinomas (86%), while being positive in a low percentage of the biliary tract cancers (8%). In conclusion, this is the first report of a significantly increased claudin-4 expression in biliary tract cancers, which represents a novel feature of tumors of biliary tract origin. Claudin-4 expression seems to be a useful marker in differentiating biliary tract cancers from hepatocellular carcinomas and could well become a potential diagnostic tool.

AB - The recently identified claudins are dominant components of tight junctions, responsible for cell adhesion, polarity and paracellular permeability. Certain claudins have been shown to have relevance in tumor development, with some of them, especially claudin-4, even suggested as future therapeutic target. The aim of the present study was to analyze the expression of claudin-4 in the biliary tree, biliary tract cancers and hepatocellular carcinomas. A total of 107 cases were studied: 53 biliary tract cancers, 50 hepatocellular carcinomas, 10 normal liver and 10 normal extrahepatic biliary duct samples, Immunohistochemical analysis was performed on conventional specimens and on tissue microarrays as well. Claudin-4 was further investigated by Western blot analysis and real-time RT-PCR. Intense membranous immunolabeling was found for claudin-4 in all biliary tract cancers unrelated to the primary site of origin, namely intrahepatic, extrahepatic or gallbladder cancers. Normal biliary epithelium showed weak positivity for claudin-4. In contrast, normal hepatocytes and tumor cells of hepatocellular carcinomas did not express claudin-4. The results of Western immunoblot analysis and real-time RT-PCR were in correlation with the immunohistochemical findings. Cytokeratins, as CK7 (92%) and CK19 (83%) were mostly positive in biliary tract cancers, however, one-third of hepatocellular carcinomas also expressed CK7 (34%). HSA antibody (HepPar1) reacted with the majority of hepatocellular carcinomas (86%), while being positive in a low percentage of the biliary tract cancers (8%). In conclusion, this is the first report of a significantly increased claudin-4 expression in biliary tract cancers, which represents a novel feature of tumors of biliary tract origin. Claudin-4 expression seems to be a useful marker in differentiating biliary tract cancers from hepatocellular carcinomas and could well become a potential diagnostic tool.

KW - Biliary tract cancer

KW - Claudin-4

KW - Hepatocellular carcinoma

KW - Liver

KW - Tight junction

UR - http://www.scopus.com/inward/record.url?scp=33244465342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33244465342&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800549

DO - 10.1038/modpathol.3800549

M3 - Article

C2 - 16439986

AN - SCOPUS:33244465342

VL - 19

SP - 460

EP - 469

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 3

ER -